<p>Seventy-two hours after the siRNA treatment, immunostaining for ZO-1 and VE-cadherin, components of tight junctions and adherence junctions, respectively, in HUVECs treated with control siRNA or VASH1 siRNA was performed. Bar = 50 µm. B: Protein content of ZO-1, VE-cadherin, VASH1, and β-actin in HUVECs treated with control siRNA or VASH1 siRNA was analyzed by Western blotting. C: HUVECs were transfected with the VASH1 expression vector, and stealth siRNA. The cells were extracted 48 hours later, and Western blot analysis was performed.</p
Confocal images showing the localization of E-cadherin, ZO-1 and p190B in wild type (ctrl) , N-WASP ...
<p>A: Immunoblots with antibodies to claudin-2, occludin, or ZO-1 using cells transfected with 25 nM...
<p>HeLa cells were untransfected (Un) or transfected with 25 nM siRNA to the indicated gene. Protein...
<p>(A) HUVECs were transfected with VASH1 siRNA or control siRNA. After a 72-hour incubation, Wester...
<p>(A) HUVECs were incubated in 0% FCS/αMEM, and total RNA and protein were extracted at the indicat...
<p>HUVECs were transfected with transgelin 2 siRNA or a scrambled control, and followed by lovastati...
(A) HUVECs were transfected with scrambled siRNA or striatin targeted siRNA 1, 2 or 3 for 48h. Stria...
<p>(A) HUVECs were treated with mult VN (10 µg/mL). Confocal microscopy showed continuous and organi...
<p>(A) Immunoblotting verified the degree of transgelin 2 (TAGLN2) depletion by siRNA. β-actin was e...
<p>(<b>A</b>) Activation of RhoA in BMVECs and LMVECs. At 2 days after transfection of siRNA or scra...
<p>(A) HUVECs were transfected with VASH1 siRNA or control siRNA. After a 24-hour incubation, cellul...
<p><i>A</i>. (top left) Representative immunoblot of p66<sup>Shc</sup> Ser<sup>36</sup> phosphorylat...
<p>A: The amount of FITC-dextran that passed through monolayers of HUVECs treated with control siRNA...
<p>(A) Western blots of protein extracts from A549 cells, HepG2 cells, A549 cells treated with contr...
<p>(A) RhoA, Rac1 or Cdc42 were silenced in HUVECs using 100 nM siRNA for 72 hours, and the cell lys...
Confocal images showing the localization of E-cadherin, ZO-1 and p190B in wild type (ctrl) , N-WASP ...
<p>A: Immunoblots with antibodies to claudin-2, occludin, or ZO-1 using cells transfected with 25 nM...
<p>HeLa cells were untransfected (Un) or transfected with 25 nM siRNA to the indicated gene. Protein...
<p>(A) HUVECs were transfected with VASH1 siRNA or control siRNA. After a 72-hour incubation, Wester...
<p>(A) HUVECs were incubated in 0% FCS/αMEM, and total RNA and protein were extracted at the indicat...
<p>HUVECs were transfected with transgelin 2 siRNA or a scrambled control, and followed by lovastati...
(A) HUVECs were transfected with scrambled siRNA or striatin targeted siRNA 1, 2 or 3 for 48h. Stria...
<p>(A) HUVECs were treated with mult VN (10 µg/mL). Confocal microscopy showed continuous and organi...
<p>(A) Immunoblotting verified the degree of transgelin 2 (TAGLN2) depletion by siRNA. β-actin was e...
<p>(<b>A</b>) Activation of RhoA in BMVECs and LMVECs. At 2 days after transfection of siRNA or scra...
<p>(A) HUVECs were transfected with VASH1 siRNA or control siRNA. After a 24-hour incubation, cellul...
<p><i>A</i>. (top left) Representative immunoblot of p66<sup>Shc</sup> Ser<sup>36</sup> phosphorylat...
<p>A: The amount of FITC-dextran that passed through monolayers of HUVECs treated with control siRNA...
<p>(A) Western blots of protein extracts from A549 cells, HepG2 cells, A549 cells treated with contr...
<p>(A) RhoA, Rac1 or Cdc42 were silenced in HUVECs using 100 nM siRNA for 72 hours, and the cell lys...
Confocal images showing the localization of E-cadherin, ZO-1 and p190B in wild type (ctrl) , N-WASP ...
<p>A: Immunoblots with antibodies to claudin-2, occludin, or ZO-1 using cells transfected with 25 nM...
<p>HeLa cells were untransfected (Un) or transfected with 25 nM siRNA to the indicated gene. Protein...